Results 31 - 40 of 759 : Previous 1 2 3 4 5 6 7 8 9 Next
Earnings? Yawn. Trial Data? Moving!
For Human Genome Sciences investors, the anticipation is frightening.
Of One-Time Gains and Pipelines
AstraZeneca had some of both during the third quarter.
World's Scariest Stocks: Pfizer
It may be a known unknown, but it still gives me the willies.
A few stock ideas for this market.
Saved by Emerging Markets. Sort Of.
GlaxoSmithKline's top line looks good, but the bottom is what counts.
Here's how you avoid a value trap.
Not 50% Growth, but We'll Take It
Double-digit growth is still pretty good.
How I'm Grabbing 20% Dividend Yields
Safely.
Check out these newly minted five-star stocks.
Companies You Should Buy Right Now
Don't mess around when it comes to your wealth.